| 產(chǎn)品編號 | bs-43080P |
| 英文名稱 | Recombinant SARS-Cov-2 (Omicron, B.1.1.529) Spike RBD protein (G339D, S371L, S373P, S375F, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H), C-His (HEK293) |
| 中文名稱 | 重組SARS冠狀病毒2 Omicron突變體蛋白Spike RBD(G339D, S371L, S373P, S375F, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H ) |
| 別 名 | Recombinant SARS-Cov-2 (Omicron, B.1.1.529) Spike RBD protein (G339D, S371L, S373P, S375F, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H), C-His (HEK293) |
| 理論分子量 | 26.9 kDa |
| 檢測分子量 | 36 |
| 性 狀 | Lyophilized or Liquid |
| 濃 度 | ＞0.5 mg/ml |
| 序 列 | 319-537/1273 |
| 純 度 | >90% as determined by SDS-PAGE |
| 純化方法 | AC |
| 內(nèi)毒素 | Not analyzed |
| 表達系統(tǒng) | HEK293 cell |
| 活性 | Not tested |
| 標(biāo)簽 | C-His |
| 緩 沖 液 | PBS (pH7.4). |
| 保存條件 | Stored at -70℃ or -20℃. Avoid repeated freeze/thaw cycles. |
| 注意事項 | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| 產(chǎn)品介紹 |
The SARS-CoV-2 spike (S) protein is the target of vaccine design efforts to end the COVID-19 pandemic. Despite a low mutation rate, isolates with the D614G substitution in the S protein appeared early during the pandemic, and are now the dominant form worldwide. Here, we analyze the D614G mutation in the context of a soluble S ectodomain construct. Anti-SARS-CoV-2 Spike Protein S（IgM校準(zhǔn)品） 特性：人源單抗(雙鏈抗體)，親和力高，批次質(zhì)量穩(wěn)定 識別位置：新冠病毒S蛋白RBD區(qū)域 產(chǎn)品應(yīng)用：ELISA、膠體金層析、化學(xué)發(fā)光等 儲存條件：-20℃保存，避免反復(fù)凍融。 |
| 產(chǎn)品圖片 |
Measured by its binding ability in a functional ELISA. Immobilized human ACE2, His-Avi Tag (Cat: bs-46001P) at 2μg/mL (100 μL/Well) can bind SARS-CoV-2 Spike RBD (G339D, S371L, S373P, S375F, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H), His Tag (Cat: bs-43080P), the EC50 is 37ng/mL.
The purity of the protein is greater than 90% as determined by reducing SDS-PAGE.
|
